NVCR.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
symbol | last | change | %chng | name | mcap | sector | wiki | |
---|---|---|---|---|---|---|---|---|
NVCR | US | Novocure Ltd |
Market global news for NVCR (US) Novocure Ltd
Global news - US chevrons indicate local prediction, arrows show global predictions
previous days
NovoCure Limited (NASDAQ:NVCR) Shares Purchased by C WorldWide Group Holding A S modernreaders - 21:45 Sat 27 - NVCR - link story | |
Results of Novocure's METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024 marketscreener - 15:15 Wed 24 - NVCR - link story | |
NovoCure : Corporate responsibility report marketscreener - 17:30 Mon 22 - NVCR - link story | |
NovoCure (NASDAQ:NVCR) Stock Rating Reaffirmed by Piper Sandler wkrb13 - 09:00 Sun 14 - NVCR - link story | |
NovoCure (NASDAQ:NVCR) Stock Rating Reaffirmed by Piper Sandler theenterpriseleader - 09:00 Sun 14 - NVCR - link story | |
NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of "Moderate Buy" by Analysts themarketsdaily - 11:30 Fri 12 - NVCR - link story | |
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of "Moderate Buy" from Analysts tickerreport - 08:30 Wed 10 - NVCR - link story | |
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages dailypolitical - 08:15 Wed 10 - NVCR - link story | |
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024 wallstreet-online de - 12:15 Fri 5 - NVCR - link story | |
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024 marketscreener - 11:30 Fri 5 - NVCR - link story | |
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts insidermonkey - 17:15 Thu 4 - NVCR - link story | |
Head to Head Contrast: Minerva Surgical (NASDAQ:UTRS) and NovoCure (NASDAQ:NVCR) wkrb13 - 08:45 Tue 2 - NVCR - link story | |
Novocure to Report First Quarter 2024 Financial Results wallstreet-online de - 12:00 Mon 1 - NVCR - link story | |
Novocure to Report First Quarter 2024 Financial Results yahoo - 11:30 Mon 1 - NVCR - link story | |
NovoCure's (NVCR) "Neutral" Rating Reaffirmed at Wedbush dailypolitical - 08:30 Sun 31 - NVCR - link story | |
NovoCure (NASDAQ:NVCR) Price Target Raised to $24.00 at HC Wainwright theenterpriseleader - 08:00 Sun 31 - NVCR - link story | |
Why NovoCure Stock Soared 18.3% This Week fool - 13:00 Sat 30 - NVCR - link story | |
Why NovoCure Stock Soared 18.3% This Week yahoo - 12:30 Sat 30 - NVCR - link story | |
NovoCure (NASDAQ:NVCR) Earns "Neutral" Rating from Wedbush theenterpriseleader - 08:15 Sat 30 - NVCR - link story | |
Why Novocure Stock Is Jumping Today yahoo - 16:45 Thu 28 - NVCR - link story | |
Why Novocure Stock Is Jumping Today | The Motley Fool fool - 16:15 Thu 28 - NVCR - link story | |
NovoCure (NASDAQ:NVCR) Trading Up 4.8% Following Analyst Upgrade themarketsdaily - 15:00 Thu 28 - NVCR - link story | |
Novocure's Electrical Cancer Therapy Shows It Can Treat Tumors in the Brain medcitynews - 02:15 Thu 28 - NVCR - link story | |
Peeling Back The Layers: Exploring NovoCure Through Analyst Insights - NovoCure (NASDAQ:NVCR) benzinga - 21:15 Wed 27 - NVCR - link story | |
Novocure's stock surges after positive results in brain-cancer trial biztoc - 21:00 Wed 27 - NVCR - link story | |
Novocure device slows spread of lung cancer to brain in late-stage study proactiveinvestors - 16:30 Wed 27 - NVCR - link story | |
Novocure Stock Soars After Wearable Device Shows Promise In Brain Tumors investors - 15:45 Wed 27 - NVCR - link story | |
Why Is Novocure Stock Trading Higher On Wednesday? biztoc - 15:45 Wed 27 - NVCR - link story | |
Sector Update: Health Care -March 27, 2024 at 09:09 am EDT marketscreener - 15:15 Wed 27 - NVCR - link story | |
Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment biztoc - 15:15 Wed 27 - NVCR - link story | |
Novocure's lung cancer therapy succeeds in late-stage trial kelo - 14:30 Wed 27 - NVCR - link story | |
Novocure (NVCR) shares jump after trial meets primary endpoint streetinsider - 14:30 Wed 27 - NVCR - link story | |
Novocure's lung cancer device slows progression to brain in trial, shares rise saltwire - 13:45 Wed 27 - NVCR - link story | |
Novocure: METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer finanznachrichten de - 11:30 Wed 27 - NVCR - link story | |
Novocure (NVCR) Reports Phase 3 METIS Trial Met Primary Endpoint streetinsider - 11:30 Wed 27 - NVCR - link story | |
NovoCure (NASDAQ:NVCR) Price Target Raised to $17.00 tickerreport - 15:00 Wed 20 - NVCR - link story | |
NovoCure (NASDAQ:NVCR) Price Target Raised to $17.00 wkrb13 - 15:00 Wed 20 - NVCR - link story |